Skip to main content
. Author manuscript; available in PMC: 2021 Jul 21.
Published in final edited form as: N Engl J Med. 2020 Nov 13;384(3):216–228. doi: 10.1056/NEJMoa2028220

Figure 2. Effects of the Polypill, as Compared with Placebo, on Clinical Outcomes.

Figure 2

Panel A shows the cumulative incidence of a first composite-primary-outcome event (death from cardiovascular causes, myocardial infarction, stroke, heart failure, resuscitated cardiac arrest, or arterial revascularization) for the comparison of the polypill with placebo. Panel B shows the cumulative incidence of first and recurrent events of the primary composite outcome. Insets show the same data on an enlarged y axis.